Moonlake Immunotherapeutics (MLTX) — 10-K Filings
All 10-K filings from Moonlake Immunotherapeutics. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
MoonLake Immunotherapeutics Files 2024 10-K
— Feb 26, 2025 Risk: medium
MoonLake Immunotherapeutics filed its 2024 10-K on February 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Helix Acquisi -
MoonLake Immunotherapeutics Files 2023 Annual Report
— Feb 29, 2024 Risk: low
MoonLake Immunotherapeutics (MLTX) filed a Annual Report (10-K) with the SEC on February 29, 2024. MoonLake Immunotherapeutics, formerly Helix Acquisition Corp,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX